Manuel J. Cuesta, MD, PhD

  • 5Articles
  • 25.7KReads
  • 2010–2025Active
  • 40Collaborators
  • 288Citations

About

Manuel J. Cuesta, MD, PhD, is affiliated with the Servicio de Psiquiatría at Hospital Universitario de Navarra and the Instituto de Investigación Sanitaria de Navarra (IdiSNA) in Pamplona, Spain. His publications, spanning from 2010 to 2025, focus on schizophrenia, schizoaffective disorders, bipolar disorder, cognition, impulse-control disorders, and psychotic disorders. His research includes studies on biomarkers related to cognition in first-episode psychosis, predictors of early versus adult onset psychosis, diagnostic differentiation between bipolar disorder and schizophrenia, persistent negative symptoms, and the effects of antipsychotic medications on neuromotor abnormalities.

Publications

JCP
VEGF and Other Biomarkers in Cognition of First Episode Psychosis
Original Research

VEGF and Other Biomarkers in Cognition of First Episode Psychosis

July 9, 2025

VEGF levels were significantly higher in the first-episode psychosis group than in the control group. The preliminary results suggest that increase in VEGF might help preserve social cognition after...
, , , et al
JCP
Original Research

Predictors of Early-Onset vs Adult-Onset Psychosis

September 14, 2021

Most research on first-episode psychosis has focused on adults. This study aimed to explore differences in early-life characteristics of patients with early-onset versus those with adult-onset psychotic disorders and...
, , , et al
JCP
Original Research

Predictors of Bipolar Disorder in First Psychotic Episode

November 3, 2020

What features may predict bipolar disorder vs schizophrenia in a person with first-episode psychosis? In this journal CME activity, find out which tools could most aid diagnosis.
, , , et al
JCP
Article

Persistent Negative Symptoms in First-Episode Psychosis

September 12, 2017

Although negative symptoms of psychosis may be less prominent than positive symptoms, they can still have an equally great impact on patient functioning. This study of patients with a...
, , , et al
PCC
Article

The Effect of Antipsychotic Medication on Neuromotor Abnormalities in Neuroleptic-Naive Nonaffective Psychotic Patients: A Naturalistic Study With Haloperidol, Risperidone, or Olanzapine

March 4, 2010

To answer this question, this study examined the effect of antipsychotic medication on neuromotor abnormalities in psychotic patients who had not been exposed to antipsychotic drugs.
,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe